Healthy lifestyle lowers risk of dementia caused by white matter ... 06 Mar 2006
...of the memory and aging program at Butler Hospital in Providence, RI, said more than half a dozen trials of Alzheimer's drugs - donepezil, galantamine and ... - Canada.com,
Canadian claims to have developed world's first blood test for ... 06 Mar 2006
At present, there is no cure for Alzheimer's, but there are treatments (such as donepezil, marketed under the name Aricept) aimed at mitigating the disease. ... - TODAYonline,
Oncology Pipeline Leads to New Eisai Inc. Research Triangle Park ... Feb 27, 2006
The existing facility encompasses approximately 190,000 square feet and is devoted to manufacturing Aricept® (donepezil hydrochloride tablets) and Aciphex ... - Yahoo! News (press release)
FDA Accepts Eisai's SNDA Application For ARICEPT® In The ... Feb 20, 2006
Shimizu) announced that the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for ARICEPT® (donepezil HCl tablets ... - Medical News Today (press release),
Oncology Pipeline Leads to New Eisai Inc. Research Triangle Park ... Feb 27, 2006
...since 2001." The existing facility encompasses approximately 190,000 square feet and is devoted to manufacturing Aricept(R) (donepezil hydrochloride tablets ... - PR Newswire (press release),
Evotec completes Phase I component for Alzheimer’s drug Feb 8, 2006
AchI). This market has been dominated by Pfizer's Aricept (donepezil), which holds over 50 per cent of the global market. Novartis's ... - In-PharmaTechnologist.com,
Health Tip: There's No Cure for Alzheimer's Feb 9, 2006
Drugs such as tacrine (Cognex), donepezil (Aricept), rivastigmine (Exelon), or galantamine (Razadyne) can slow the progression of the disease but cannot stop ... - Forbes
Improving Alzheimer’s treatment Feb 6, 2006
...“Since then, we’ve seen the development of a class of drugs known as cholinesterase inhibitors, for example, donepezil (Aricept), rivastigmine (Exelon) and ... - San Bernardino Sun,
Blood Flow Imaging of the Brain: 50 Years Experience Feb 9, 2006
Tanaka M, Namiki C, Thuy DH, et al: Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer’s disease. ... - Journal of Neuropsychiatry (subscription)
Stephan Heres, MD , John Davis, MD , Katja Maino, MD , Elisabeth ... Feb 9, 2006
C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P: Long-term donepezil treatment in ... - Am J Psychiatry (subscription)
Drug Side Effects Can Befuddle Elderly Feb 1, 2006
...aim of research into mild cognitive impairment has been to slow the progress to dementia with pro-cholinergic drugs, such as Aricept (donepezil) or Reminyl ... - CNN
Health Tip: There's No Cure for Alzheimer's 09 Feb 2006
Drugs such as tacrine (Cognex), donepezil (Aricept), rivastigmine (Exelon), or galantamine (Razadyne) can slow the progression of the disease but cannot stop ... - Forbes
Donepezil for dementia due to Alzheimer's disease Jan 25, 2006
Trials lasting up to 12 months show that taking daily doses of either 5mg or 10mg donepezil improves cognition and global clinical state in patients with ... - News-Medical.net,
Evotec completes Phase I component for Alzheimer’s drug Feb 8, 2006
AchI). This market has been dominated by Pfizer's Aricept (donepezil), which holds over 50 per cent of the global market. Novartis's ... - In-PharmaTechnologist.com,
Improving Alzheimer’s treatment Feb 6, 2006
...“Since then, we’ve seen the development of a class of drugs known as cholinesterase inhibitors, for example, donepezil (Aricept), rivastigmine (Exelon) and ... - San Bernardino Sun,
Alzheimer's drug could make everyone brainier Jan 26, 2006
A study published in the journal Psychopharmacology of the affect of the Alzheimer's drug Donepezil on 30 healthy male students conducted in Germany last year ... - The Observer,
NICE Consults On Revised First Draft Guidance On The Use Of Drugs ... Jan 24, 2006
The National Institute for Health and Clinical Excellence (NICE) is consulting on the revised draft of its review of donepezil, rivastigmine, galantamine and ... - Medical News Today (press release),
NeuroSearch Continues the Development of Tesofensine (NS2330) and ... Jan 25, 2006
In a safety and tolerability study of 0.25 mg, 0.5 mg, and 1 mg tesofensine or placebo daily for 14 weeks as an add-on to 10 mg donepezil (Aricept®) in 92 ... - PharmaLive.com (press release),
Alzheimer's drugs to be available to NHS patients Jan 22, 2006
In the draft, NICE accepted that donepezil, rivastigmine, galantamine and memantine - known as cholinesterase inhibitors - could alleviate the symptoms of ... - Independent,
Drug Side Effects Can Befuddle Elderly Feb 1, 2006
...aim of research into mild cognitive impairment has been to slow the progress to dementia with pro-cholinergic drugs, such as Aricept (donepezil) or Reminyl ... - CNN
Alzheimer's and the need for swift treatment Jan 30, 2006
...s. There are two other drugs that work in the same way as Aricept (donepezil) — Reminyl (galantamine) and Exelon rivastigmine. ... - Times Online,
Noel Gallagher is my choice for monarch Jan 29, 2006
It has been discovered that if a perfectly healthy person takes the Alzheimer’s medication donepezil, it improves the memory and reasoning functions. ... - Times Online,
Veggie-burger blues: Soy slips as cholesterol reducer Jan 27, 2006
...by pharmaceutical companies, involved three widely used drugs for the mind-destroying disease: Aricept (generically known as donepezil), Exelon (rivastigmine ... - Globe and Mail,
Antipsychotics and dementia: the good and bad news Jan 31, 2006
Drugs designed to help Alzheimer's patients, such as donepezil (sold as Aricept) and tacrine (sold as Cognex), work by boosting levels of messenger chemicals ... - WTOP,
Alzheimer's Drugs Aricept, Razadyne And Exelon Offer Modest ... Jan 25, 2006
Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. The Cochrane Database of Systematic Reviews 2006, Issue 1. ... - Medical News Today (press release),
Thousands of Scots Alzheimer's sufferers will be denied drugs Jan 22, 2006
At the moment the drugs donepezil (Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are all available for mild to moderate Alzheimer's on the NHS. ... - Scotsman,
Alzheimer sufferers win £60m drug fight Jan 21, 2006
Three of the drugs, rivastigmine (brand name Exelon), donepezil (Aricept) and galantamine (Reminyl), cost around £2.50 per day per patient, resulting in an ... - The Observer,
Alzheimer's drugs policy reviewed Jan 22, 2006
Donepezil, rivastigmine and galantamine would be funded but only when new patients reach a moderate stage of the condition. The ... - BBC News,
UK - New guidance on Alzheimer's drugs Jan 23, 2006
The appraisal committee's proposals on donepezil, galantamine and rivastigmine would mean patients in the early stages of Alzheimer's would be denied the drugs ... - Monsters and Critics.com,
RCP: Nice guidance is still flawed Jan 23, 2006
Nice has proposed that donepezil, galantamine and rivastigmine could be prescribed only to people with moderate to severe symptoms of the disease. ... - Politics.co.uk,
Nice reverses Alzheimer's drug decision Jan 23, 2006
However, the recommendations from the National Institute for Health and Clinical Excellence (Nice) would mean that donepezil, galantamine and rivastigmine ... - Politics.co.uk,
Anger over Alzheimer's drugs ruling Jan 23, 2006
Draft guidance published by the National Institute for Health and Clinical Excellence (NICE) recommended that donepezil, rivastigmine and galantamine should ... - 4ni.co.uk,
Alzheimer's Society: Nice decision is mixed Jan 23, 2006
Nice is consulting on recommendations that patients with moderately severe Alzheimer's disease should have access to donepezil, rivastigmine, galantamine. ... - Politics.co.uk,
Nice: Alzheimer's patients will benefit from decision Jan 23, 2006
Nice recommended that patients with moderately severe Alzheimer's diseases should have access to donepezil, galantamine and rivastigmine on the NHS, but said ... - Politics.co.uk,
Today's issue...Alzheimer's drugs Jan 23, 2006
The decision signals a U-turn on the watchdog's announcement in March last year that donepezil, rivastigmine, galantamine - which cost £2.50 a day - were not ... - Politics.co.uk,
DEMENTIA sufferers have been given fresh hope after a U-turn by ... Jan 23, 2006
...condition. But the drugs - donepezil, rivastigmine and galantamine - will only be prescribed to people with moderate symptoms. There ... - Glasgow Daily Record,
Cognitive Disorder NOS With Arnold-Chiari I Malformation Jan 23, 2006
Salloway S, Ferris S, Kluger A, et al: Efficacy of donepezil in mild cognitive impairment: a randomized, placebo-controlled trial. ... - Psychosomatics (subscription)
Eisai sues Teva for patent infringement Dec 8, 2005
...to the US Food & Drug Administration of an abbreviated new drug application (ANDA) for Aricept, the main ingredient of which is donepezil hydrochloride. ... - Jerusalem Post,
Eisai Initiates US Legal Action over Aricept ANDA Filing Dec 8, 2005
Industries regarding its submission of an abbreviated new drug application (ANDA) to the FDA for Aricept, Active Ingredient Name donepezil hydrochloride, in ... - Japan Corporate News (press release),
Eisai Commences US Legal Action over Aricept ANDA Filing Dec 8, 2005
...against Teva* regarding its submission of an abbreviated new drug application (ANDA) to the FDA for Aricept(R) (Active Ingredient Name: donepezil hydrochloride ... - PharmaLive.com (press release),
Japan's Eisai sues Teva over generic Aricept ANDA filing Dec 8, 2005
TEVA; TASE: TEVA) regarding its submission of an abbreviated new drug application (ANDA) to the FDA for Aricept (active ingredient: donepezil hydrochloride). ... - Globes,
Apathy and Its Treatment in Alzheimer's Disease and Other ... Dec 5, 2005
Large-scale clinical trials have generally indicated that donepezil (Aricept) improves neuropsychiatric functioning, particularly the symptom of apathy (Birks ... - Psychiatric Times,
Cortical Activation During Cholinesterase-Inhibitor Treatment in ... Nov 13, 2005
...faces. Patients were scanned again after a 10-week open treatment with the cholinesterase-inhibitor donepezil. Results ... Inhibitors. Donepezil. One ... - Am J Geriatric Psychiatry (subscription)
Fitzpatrick Cella Commences Legal Action on Behalf of Clients ... Dec 7, 2005
Pharmaceuticals over its submission of an abbreviated new drug application (ANDA) to the FDA for Aricept(r) (Active Ingredient Name: donepezil hydrochloride). ... - PharmaLive.com (press release),
Business news in brief Dec 9, 2005
Ltd., said yesterday that it filed the lawsuit after Teva asked for Food and Drug Administration permission to market a copy of Aricept, chemical name donepezil ... - Philadelphia Inquirer,
Eisai Files Suit Against Teva Dec 8, 2005
Administration. Eisai claims it has rights to the drug’s active ingredient, donepezil hydrochloride, until November 25, 2010. ... - Business New Jersey (subscription),
Cholinesterase inhibitors: in search of cholinergic deficits Sep 16, 2005
These confirm the findings of the 2001 guidelines that donepezil, rivastigmine and galantamine are effective and safe in the treatment of Alzheimer’s disease ... - Adv Psychiatric Treat (subscription)
Understanding dementia Sep 23, 2005
These are donepezil, rivastigmine, memantine and galantamine. The first three drugs are widely available in India. While there are ... - News Today,
Intake Of Dietary Copper Helps Alzheimer's Patients Oct 4, 2005
Be Delayed, Says Major Clinical Trial (April 14, 2005) -- In a study of people with mild cognitive impairment (MCI), those who took the drug donepezil were at ... - Science Daily (press release)
The pill for every ill Sep 27, 2005
Patients with Alzheimer’s disease and normal cholesterol levels are being treated with either donepezil (Aricept) combined with atorvastatin, or donepezil ... - AustralianDoctor.com (subscription),
Eisai Submits Application to FDA for ARICEPT® for Treatment of ... Sep 10, 2005
Mindell Seidlin, MD) has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration for ARICEPT® (donepezil HCl tablets) for ... - I-Newswire.com (press release)
Eisai Inc. and US Pharmacist Honor Pharmacists for Outstanding ... Sep 13, 2005
As the discoverer and developer of Aricept® (donepezil hydrochloride tablets), the number-one prescribed medication worldwide for mild-to-moderate Alzheimer's ... - Market Wire (press release)
Alzheimer's sufferers hit by further delay in NHS approval for ... Sep 17, 2005
The drugs - rivastigmine (Exelon), donepezil (Aricept) and galantamine (Reminyl) - cost around £2.50 per day per patient, resulting in an NHS bill of £60 ... - Telegraph.co.uk,
Eisai eyes key pharma ties Sep 13, 2005
Eisai India has launched Aricep (donepezil hydrochloride) for dementia of Alzheimer type. Globally, the product clocks revenues of $ 1.5billion. ... - Business Standard,
Distraction underlies memory problems with aging Sep 15, 2005
Based on this, he said, the team now plans to evaluate drugs used to treat Alzheimer's disease, such as Aricept (donepezil), and different rehabilitation ... - Reuters
Japanese pharmaceutical company Eisai launches its India ... Sep 13, 2005
...disorders. It has launched Aricep (donepezil hydrochloride) to treat Demetia (disorder related to memory) with Wockhardt Ltd. "We ... - India Daily,
'New' drugs too often offer little new 08 Sep 2005
...drugs include: filgrastim (sold under the brand name Neupogen), used to treat a common side effect of chemotherapy; donepezil hydrochloride (Aricept), used in ... - Globe and Mail,
Eisai Submits Application to FDA for ARICEPT® for Treatment of ... Sep 5, 2005
Mindell Seidlin, MD) has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration for ARICEPT® (donepezil HCl tablets) for ... - Medical News Today (press release),
Cholinesterase inhibitors: in search of cholinergic deficits Aug 31, 2005
These confirm the findings of the 2001 guidelines that donepezil, rivastigmine and galantamine are effective and safe in the treatment of Alzheimer’s disease ... - Adv Psychiatric Treat (subscription)
Eisai Submitted Application to FDA for Aricept for Treatment of ... Sep 2, 2005
President Mindell Seidlin, MD), submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration for ARICEPT (donepezil HCl tablet ... - PharmaLive.com (press release),
Eisai: Aricept in for severe approval Sep 2, 2005
Co-promoted in the US by Eisai and Pfizer, Aricept (donepezil hydrochloride) is currently only approved for the treatment of mild to moderate AD but is widely ... - Pharmaceutical Business Review
Namenda Alzheimer’s Medication Now Available in Liquid Aug 19, 2005
...and Drug Administration has approved four prescription drugs for people with mild-to-moderate AD: Cognex (tacrine), Aricept (donepezil), Exelon (rivastigmine ... - SeniorJournal.com,
Update in General Internal Medicine Aug 5, 2005
Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. ... - RedNova.com
Sufferers demand a voice Aug 3, 2005
The charity is to lobby city MPs to keep to keep the drugs, donepezil, rivastigmine, galantamine and memantine, funded on the NHS. ... - Sheffield Today
The Cognitive Effects of Cholinesterase Inhibitor Treatment in ... Jul 13, 2005
The release of cholinesterase inhibitors (ChEIs), namely tacrine, donepezil, rivastigmine and galantamine constitute a significant progress in Alzheimer's ... - RedNova.com
Bitter Pill Jul 14, 2005
The coverage of an older drug called donepezil, marketed by Pfizer under the brand name Aricept, is a case in point. In April, The ... - Columbia Journalism Review
On the rounds Jul 31, 2005
Excellence (NICE) has asked for more evidence from pharmaceutical firms before publishing the final draft of its review of donepezil, rivastigmine, galantamine ... - Scotsman
Update on the NICE appraisal of Alzheimer's drugs Jul 23, 2005
NICE) has requested more evidence from pharmaceutical companies before publishing the final draft of its review of donepezil, rivastigmine, galantamine and ... - I-Newswire.com (press release)
Trust me I'ma junior doctor: it's too easy to forget dementia Jul 25, 2005
Among doctors, it was well-known that these drugs - donepezil, rivastigmine, galantamine, and more recently memantine - offered only the faintest glimmer of ... - Telegraph.co.uk
Delays In Alzheimers Drug Appalling - MLA Jul 23, 2005
Clinical Excellence had put forward draft guidance in March after assessing the clinical and cost effectiveness of using memantine, donepezil, rivastigmine and ... - News Letter
Alzheimer's patients despair as drug decision is delayed Jul 18, 2005
The drugs, donepezil, rivastigmine, galantamine and memantine, were approved for use on the NHS in 2001 and will continue to be state-funded while the review ... - Guardian Unlimited
Dementia drug delays spark anger Jul 18, 2005
But in a statement Nice said the final draft of its review of the drugs donepezil, rivastigmine, galantamine and memantine would be delayed after it requested ... - Daily Mail - UK
Issues of the day…Delay on Alzheimer’s drugs decision Jul 19, 2005
In March Nice proposed a restriction in the use of rivastigmine, memantine, donepezil and galantamine because they did not represent good value for money. ... - Politics.co.uk
Remember: Grandma's Alzheimer's Drug Can Be Poison to Baby Jul 21, 2005
As a pharmaceutical used to treat Alzheimer's, Exelon - like Cognex (tacrine), Aricept (donepezil), and Reminyl (galantamine) -- is one of the classes of ... - MedPage Today
Heat Wave Sweeps Much of Nation, With Health Risks Everywhere Jul 20, 2005
Dr. Braver said Aricept (donepezil), which is approved for treatment of mild to moderate Alzheimer's disease, also reduces heat tolerance. ... - MedPage Today
| 
